148 related articles for article (PubMed ID: 21782526)
41. Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses.
Gillespie EJ; Ho CL; Balaji K; Clemens DL; Deng G; Wang YE; Elsaesser HJ; Tamilselvam B; Gargi A; Dixon SD; France B; Chamberlain BT; Blanke SR; Cheng G; de la Torre JC; Brooks DG; Jung ME; Colicelli J; Damoiseaux R; Bradley KA
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):E4904-12. PubMed ID: 24191014
[TBL] [Abstract][Full Text] [Related]
42. [Looking for an antidote against A/B toxins].
Moreau D; Bard F
Med Sci (Paris); 2012 Jan; 28(1):28-31. PubMed ID: 22289824
[No Abstract] [Full Text] [Related]
43. An imaging flow cytometry method to assess ricin trafficking in A549 human lung epithelial cells.
Jenner D; Chong D; Walker N; Green AC
Methods; 2018 Feb; 134-135():41-49. PubMed ID: 29122725
[TBL] [Abstract][Full Text] [Related]
44. Endocytosis and intracellular transport of protein toxins.
Sandvig K; Garred O; Holm PK; van Deurs B
Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):707-11. PubMed ID: 8224494
[No Abstract] [Full Text] [Related]
45. Intracellular transport of plant toxins ricin and viscumin from different plasma membrane sites.
Moisenovich M; Agapov I; Marx U; Bereiter-Hahn J; Tonevitsky A
Arzneimittelforschung; 2003; 53(6):470-5. PubMed ID: 12872616
[TBL] [Abstract][Full Text] [Related]
46. The anti-tumor drug 2-hydroxyoleic acid (Minerval) stimulates signaling and retrograde transport.
Torgersen ML; Klokk TI; Kavaliauskiene S; Klose C; Simons K; Skotland T; Sandvig K
Oncotarget; 2016 Dec; 7(52):86871-86888. PubMed ID: 27894086
[TBL] [Abstract][Full Text] [Related]
47. Inhibitors of retrograde trafficking active against ricin and Shiga toxins also protect cells from several viruses, Leishmania and Chlamydiales.
Gupta N; Noël R; Goudet A; Hinsinger K; Michau A; Pons V; Abdelkafi H; Secher T; Shima A; Shtanko O; Sakurai Y; Cojean S; Pomel S; Liévin-Le Moal V; Leignel V; Herweg JA; Fischer A; Johannes L; Harrison K; Beard PM; Clayette P; Le Grand R; Rayner JO; Rudel T; Vacus J; Loiseau PM; Davey RA; Oswald E; Cintrat JC; Barbier J; Gillet D
Chem Biol Interact; 2017 Apr; 267():96-103. PubMed ID: 27712998
[TBL] [Abstract][Full Text] [Related]
48. Modeling of toxin-antibody interaction and toxin transport toward the endoplasmic reticulum.
Skakauskas V; Katauskis P
J Biol Phys; 2016 Jan; 42(1):83-97. PubMed ID: 26306534
[TBL] [Abstract][Full Text] [Related]
49. Structure-Activity Relationship Studies of Retro-1 Analogues against Shiga Toxin.
Abdelkafi H; Michau A; Pons V; Ngadjeua F; Clerget A; Ait Ouarab L; Buisson DA; Montoir D; Caramelle L; Gillet D; Barbier J; Cintrat JC
J Med Chem; 2020 Aug; 63(15):8114-8133. PubMed ID: 32648758
[TBL] [Abstract][Full Text] [Related]
50. Intracellular antibodies do not affect transport of protein toxins.
Moisenovich MM; Agapov II; Egorova SG; Tchelnokova OV; Kozlovskaia NV; Fattakhova GV; Bereiter-Hahn J; Tonevitsky AG
Dokl Biochem Biophys; 2001; 379():247-51. PubMed ID: 11605337
[No Abstract] [Full Text] [Related]
51. Revisiting Old Ionophore Lasalocid as a Novel Inhibitor of Multiple Toxins.
Mahtal N; Wu Y; Cintrat JC; Barbier J; Lemichez E; Gillet D
Toxins (Basel); 2020 Jan; 12(1):. PubMed ID: 31906353
[TBL] [Abstract][Full Text] [Related]
52. Viral infection permeabilizes mammalian cells to protein toxins.
Fernández-Puentes C; Carrasco L
Cell; 1980 Jul; 20(3):769-75. PubMed ID: 6251972
[No Abstract] [Full Text] [Related]
53. RNAi screens for genes involved in Golgi glycosylation.
Goh GY; Bard FA
Methods Mol Biol; 2015; 1270():411-26. PubMed ID: 25702132
[TBL] [Abstract][Full Text] [Related]
54. Insights to transcriptional networks by using high throughput RNAi strategies.
Mattila J; Puig O
Brief Funct Genomics; 2010 Jan; 9(1):43-52. PubMed ID: 19952073
[TBL] [Abstract][Full Text] [Related]
55. Penetration of protein toxins into cells.
Falnes PO; Sandvig K
Curr Opin Cell Biol; 2000 Aug; 12(4):407-13. PubMed ID: 10873820
[TBL] [Abstract][Full Text] [Related]
56. Protein toxins acting on intracellular targets: cellular uptake and translocation to the cytosol.
Olsnes S; van Deurs B; Sandvig K
Med Microbiol Immunol; 1993 May; 182(2):51-61. PubMed ID: 8392658
[No Abstract] [Full Text] [Related]
57. Digging deep into Golgi phenotypic diversity with unsupervised machine learning.
Hussain S; Le Guezennec X; Yi W; Dong H; Chia J; Yiping K; Khoon LK; Bard F
Mol Biol Cell; 2017 Dec; 28(25):3686-3698. PubMed ID: 29021342
[TBL] [Abstract][Full Text] [Related]
58. Protein toxins: mode of action and cell entry.
Sandvig K; Dubinina E; Garred O; Prydz K; Kozlov JV; Hansen SH; van Deurs B
Biochem Soc Trans; 1992 Nov; 20(4):724-7. PubMed ID: 1487049
[No Abstract] [Full Text] [Related]
59. Inhibitors of the cellular trafficking of ricin.
Barbier J; Bouclier C; Johannes L; Gillet D
Toxins (Basel); 2012 Jan; 4(1):15-27. PubMed ID: 22347620
[TBL] [Abstract][Full Text] [Related]
60. How do toxins penetrate cells?
Hughes RC
Nature; 1979 Oct; 281(5732):526-7. PubMed ID: 492314
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
